1. Antitumor cytotoxic T-cell response induced by a survivin peptide mimic. Ciesielski MJ, Ahluwalia MS, Munich SA, Orton M, Barone T, Chanan-Khan A, Fenstermaker RA. Cancer Immunol Immunother. 2010 Aug;59(8):1211-21. Epub 2010 Apr 27.
2. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. Yang W, Barth RF, Wu G, Huo T, Tjarks W, Ciesielski M, Fenstermaker RA, Ross BD, Wikstrand CJ, Riley KJ, Binns PJ. J Neurooncol. 2009 Dec;95(3):355-65. Epub 2009 Jul 9.
3. Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting. Paul AK, Ciesielski MJ, Sajjad M, Wang X, Ferrone S, Abdel-Nabi H, Fenstermaker RA. J Neurooncol. 2009 Aug;94(1):21-30. Epub 2009 Jan 20.
4. Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells. Wierzbicki A, Gil M, Ciesielski M, Fenstermaker RA, Kaneko Y, Rokita H, Lau JT, Kozbor D. J Immunol. 2008 Nov 1;181(9):6644-53.
5. EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination? Fenstermaker RA, Ciesielski MJ. Curr Genomics. 2007 May;8(3):163-70.
6. Central nervous system cancers. Brem SS, Bierman PJ, Black P, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Glass J, Grossman SA, Heimberger AB, Junck L, Linette GP, Loeffler JJ, Maor MH, Moots P, Mrugala M, Nabors LB, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Shrieve DC, Sills AK Jr. J Natl Compr Canc Netw. 2008 May;6(5):456-504.
7. Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma. Ciesielski MJ, Kozbor D, Castanaro CA, Barone TA, Fenstermaker RA. Cancer Immunol Immunother. 2008 Dec;57(12):1827-35. Epub 2008 Apr 26.